These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19834375)

  • 1. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
    Grossetete M; Phelps J; Arko L; Yonas H; Rosenberg GA
    Neurosurgery; 2009 Oct; 65(4):702-8. PubMed ID: 19834375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential disruption of blood-brain barrier in severe traumatic brain injury.
    Saw MM; Chamberlain J; Barr M; Morgan MP; Burnett JR; Ho KM
    Neurocrit Care; 2014 Apr; 20(2):209-16. PubMed ID: 24233818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 in the ventricular cerebrospinal fluid correlated with the prognosis of traumatic brain injury.
    Liu CL; Chen CC; Lee HC; Cho DY
    Turk Neurosurg; 2014; 24(3):363-8. PubMed ID: 24848175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury.
    Minta K; Brinkmalm G; Al Nimer F; Thelin EP; Piehl F; Tullberg M; Jeppsson A; Portelius E; Zetterberg H; Blennow K; Andreasson U
    Sci Rep; 2020 Oct; 10(1):18075. PubMed ID: 33093584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.
    Candelario-Jalil E; Thompson J; Taheri S; Grossetete M; Adair JC; Edmonds E; Prestopnik J; Wills J; Rosenberg GA
    Stroke; 2011 May; 42(5):1345-50. PubMed ID: 21454822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
    Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
    Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage.
    Chou SH; Lee PS; Konigsberg RG; Gallacci D; Chiou T; Arai K; Simmons S; Bauer D; Feske SK; Lo EH; Ning M
    Stroke; 2011 Dec; 42(12):3624-7. PubMed ID: 21940962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis.
    Marangoni NR; Melo GD; Moraes OC; Souza MS; Perri SH; Machado GF
    Parasite Immunol; 2011 Jun; 33(6):330-4. PubMed ID: 21332759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.
    Vilalta A; Sahuquillo J; Rosell A; Poca MA; Riveiro M; Montaner J
    Intensive Care Med; 2008 Aug; 34(8):1384-92. PubMed ID: 18350273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.
    Hanrieder J; Wetterhall M; Enblad P; Hillered L; Bergquist J
    J Neurosci Methods; 2009 Mar; 177(2):469-78. PubMed ID: 19263575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
    Pentz R; Iulita MF; Ducatenzeiler A; Videla L; Benejam B; Carmona‐Iragui M; Blesa R; Lleó A; Fortea J; Cuello AC
    Alzheimers Dement; 2021 Apr; 17(4):605-617. PubMed ID: 33226181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
    Li YJ; Wang ZH; Zhang B; Zhe X; Wang MJ; Shi ST; Bai J; Lin T; Guo CJ; Zhang SJ; Kong XL; Zuo X; Zhao H
    J Neuroinflammation; 2013 Jul; 10():80. PubMed ID: 23829879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Tsai HC; Chung LY; Chen ER; Liu YC; Lee SS; Chen YS; Sy CL; Wann SR; Yen CM
    Am J Trop Med Hyg; 2008 Jan; 78(1):20-7. PubMed ID: 18187780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
    J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
    Pérez-Bárcena J; Crespí C; Frontera G; Llompart-Pou JA; Salazar O; Goliney V; Ibáñez J; Bullock MR; de Rivero Vaccari JP
    J Neurosurg; 2021 May; 134(5):1644-1649. PubMed ID: 32357337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ; Farhavar A; Gee C; Hawthorn B; He H; Nayak A; Stöcklein V; Bazarian JJ
    J Neurotrauma; 2009 Sep; 26(9):1497-1507. PubMed ID: 19257803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
    Yushchenko M; Weber F; Mäder M; Schöll U; Maliszewska M; Tumani H; Felgenhauer K; Beuche W
    J Neuroimmunol; 2000 Oct; 110(1-2):244-51. PubMed ID: 11024556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.
    Adair JC; Charlie J; Dencoff JE; Kaye JA; Quinn JF; Camicioli RM; Stetler-Stevenson WG; Rosenberg GA
    Stroke; 2004 Jun; 35(6):e159-62. PubMed ID: 15105518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.